Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06956378 · ClinicalTrials.gov registry record · NA

Health Questionnaire Study

A NA study of Depression, Anxiety, sponsored by University of California, Irvine.

Active
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT06956378: Active NA study of Depression, Anxiety, sponsored by University of California, Irvine.

NCT06956378 is a NA study of Depression, Anxiety that is active but no longer recruiting, run by University of California, Irvine. The registered enrollment target is 200 participants, below the 420-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06956378, a NA study of Depression, Anxiety, is active but no longer recruiting, sponsored by University of California, Irvine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

We want to explore if emphasizing certain instructions (i.e. "bothered by") will affect the way participants respond to a questionnaire.

Primary Outcome

9-item questionnaire. Study is completed in 1 day. Scale is administered 2 times. Higher scores mean greater depressive symptoms.

Conditions Studied

Interventions

  • BEHAVIORAL Instruction Emphasis

Study Locations (1)

California

  • University of California - Irvine - Orange

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2025-04-18
Est. Completion 2026-03
Phase NA
University of California, Irvine

368 total trials

What the registry record for NCT06956378 still lists

NCT06956378 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 420-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (52% lower).

The record links to 1 condition, with Depression, Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Instruction Emphasis is the first listed.

NCT06956378 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06956378 about?

NCT06956378 is a clinical study titled "Health Questionnaire Study". We want to explore if emphasizing certain instructions (i.e. "bothered by") will affect the way participants respond to a questionnaire.

What is the current status of trial NCT06956378?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-04-18. Estimated completion is 2026-03.

What conditions does trial NCT06956378 study?

This clinical trial studies the following conditions: Depression, Anxiety.

What interventions are being tested in trial NCT06956378?

The interventions under investigation include: Instruction Emphasis (BEHAVIORAL).

Who is sponsoring clinical trial NCT06956378?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06956378 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression, Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06956378's enrollment target sits among peer trials

200 16th of 40 higher than 25 of 40 other Depression, Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression, Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06956378, the US trial registry maintained by the National Library of Medicine. NCT06956378 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.